Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paolo Garneri is active.

Publication


Featured researches published by Paolo Garneri.


BioMed Research International | 2015

Use of Contrast-Enhanced Ultrasound in Carotid Atherosclerotic Disease: Limits and Perspectives

Gianfranco Varetto; Lorenzo Gibello; Claudio Castagno; Simone Quaglino; Matteo Ripepi; Emilio Benintende; Andrea Gattuso; Paolo Garneri; Stefano Zan; Giacomo Capaldi; Ugo Bertoldo; Pietro Rispoli

Contrast-enhanced ultrasound (CEUS) has recently become one of the most versatile and powerful diagnostic tools in vascular surgery. One of the most interesting fields of application of this technique is the study of the carotid atherosclerotic plaque vascularization and its correlation with neurological symptoms (transient ischemic attack, minor stroke, and major stroke) and with the characteristics of the “vulnerable plaque” (surface ulceration, hypoechoic plaques, intraplaque hemorrhage, thinner fibrous cap, and carotid plaque neovascularization at histopathological analysis of the sample after surgical removal). The purpose of this review is to collect all the original studies available in literature (24 studies with 1356 patients enrolled) and to discuss the state of the art, limits, and future perspectives of CEUS analysis. The results of this work confirm the reliability of this imaging study for the detection of plaques with high risk of embolization; however, a shared, user-friendly protocol of imaging analysis is not available yet. The definition of this operative protocol becomes mandatory in order to compare results from different centers and to validate a cerebrovascular risk stratification of the carotid atherosclerotic lesions evaluated with CEUS.


Scientific Reports | 2017

Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia

Claudia Cavallari; Andrea Ranghino; Marta Tapparo; Massimo Cedrino; Federico Figliolini; Cristina Grange; Valentina Giannachi; Paolo Garneri; Maria Chiara Deregibus; Federica Collino; Pietro Rispoli; Giovanni Camussi; Maria Felice Brizzi

Serum is an abundant and accessible source of circulating extracellular vesicles (EVs). Serum-EV (sEV) pro-angiogenic capability and mechanisms are herein analyzed using an in vitro assay which predicts sEV angiogenic potential in vivo. Effective sEVs (e-sEVs) also improved vascular remodeling and prevented muscle damage in a mouse model of acute hind limb ischemia. e-sEV angiogenic proteomic and transcriptomic analyses show a positive correlation with matrix-metalloproteinase activation and extracellular matrix organization, cytokine and chemokine signaling pathways, Insulin-like Growth Factor and platelet pathways, and Vascular Endothelial Growth Factor signaling. A discrete gene signature, which highlights differences in e-sEV and ineffective-EV biological activity, was identified using gene ontology (GO) functional analysis. An enrichment of genes associated with the Transforming Growth Factor beta 1 (TGFβ1) signaling cascade is associated with e-sEV administration but not with ineffective-EVs. Chromatin immunoprecipitation analysis on the inhibitor of DNA binding I (ID1) promoter region, and the knock-down of small mother against decapentaplegic (SMAD)1–5 proteins confirmed GO functional analyses. This study demonstrates sEV pro-angiogenic activity, validates a simple, sEV pro-angiogenic assay which predicts their biological activity in vivo, and identifies the TGFβ1 cascade as a relevant mediator. We propose serum as a readily available source of EVs for therapeutic purposes.


Korean Circulation Journal | 2015

Primary Aortoenteric Fistula of a Saccular Aneurysm: Case Study and Literature Review

Gianfranco Varetto; Lorenzo Gibello; Alessandra Trevisan; Claudio Castagno; Paolo Garneri; Pietro Rispoli

Primary aortoenteric fistula is a direct communication between the aorta and intestinal lumen and it represents a rare but potentially lethal complication of an abdominal aortic aneurysm. However, it may occur less frequently in a naive non-aneurysmatic aorta. Diagnosis is often difficult and delayed in most cases, unless there is a high level of clinical awareness. Urgent surgery is still the recommended treatment. We describe the case of primary aortoenteric fistula of a saccular aneurysm. A 55-year-old woman was referred to our center with hematemesis, melena, and severe anemia who was dignosed previously with unknown saccular abdominal aneurysm.


Annals of Vascular Surgery | 2015

Successful Management with 2 Overlapping Bare Stents for Post–Carotid Endarterectomy Carotid Pseudoaneurysm Secondary to Carotid Shunt

Gianfranco Varetto; Claudio Castagno; Simone Quaglino; Paolo Garneri; Emilio Benintende; Lorenzo Gibello; Denis Rossato; Pietro Rispoli

Pseudoaneurysms are a rare complication of carotid endarterectomy. We successfully excluded with 2 overlapping bare stents a distal carotid artery pseudoaneurysm very likely induced by a Pruitt-Inahara shunt 2 months after carotid endarterectomy.


The Korean Journal of Thoracic and Cardiovascular Surgery | 2014

Rupture of giant superficial femoral artery aneurysm in a leukemic patient submitted to chemotherapy.

Gianfranco Varetto; Claudio Castagno; Matteo Ripepi; Paolo Garneri; Simone Quaglino; Pietro Rispoli

The superficial femoral artery (SFA) is a relatively rare location for lower limb aneurysmatic disease. In the literature, this disease is described an association between a relatively high growth rate and/or the rupture of aneurysms and chemotherapeutic agents. We report a case of the rupture of a giant SFA aneurysm in a patient during chemotherapy for acute lymphatic leukemia.


Journal of Vascular Diagnostics and Interventions | 2013

Ultrasound surveillance in endoluminal laser treatment for varicose veins

Gianfranco Varetto; Paolo Garneri; Claudio Castagno; Valentina Molinaro; Simone Quaglino; Matteo Ripepi; Emilio Benintende; Lorenzo Gibello; Stefano Zan; Luigi Contessa; Ugo Bertoldo; Pietro Rispoli

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Journal of Vascular Diagnostics 2013:1 21–23 Journal of Vascular Diagnostics Dovepress


Journal of Vascular and Interventional Radiology | 2016

Bailout Chimney Technique during Endovascular Aneurysm Sealing for Accidental Renal Artery Coverage

Gianfranco Varetto; Claudio Castagno; Simone Quaglino; Paolo Garneri; Alessandra Trevisan; Matteo Destro; Denis Rossato; Pietro Rispoli

1. Andersen PE, Midtgaard A, Brenoe AS, Elle B, Duvnjak S. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience. J Cardiovasc Surg (Torino) 2015; 56:877–881. 2. Mokry T, Bellemann N, Sommer CM, et al. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer. J Vasc Interv Radiol 2015; 26:357–365. 3. Gwon DI, Ko GY, Kim JH, Shin JH, Yoon HK, Sung KB. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 2013; 266: 979–987. 4. Dinkel HP, Mettke B, Schmid F, Baumgartner I, Triller J, Do DD. Endovascular treatment of malignant superior vena cava syndrome: is bilateral Wallstent placement superior to unilateral placement? J Endovasc Ther 2003; 10:788–797


Annals of Vascular Surgery | 2016

Mediastinoscopy-assisted Treatment of an Aberrant Right Subclavian Artery

Gianfranco Varetto; Claudio Castagno; Alessandra Trevisan; Simone Quaglino; Paolo Garneri; Claudio Mossetti; Pietro Rispoli

Aberrant right subclavian artery (ARSA) is a rare congenital anomaly characterized by the origin of the right subclavian artery from the aortic arch distally to the left subclavian artery. We describe the case of a young patient with symptomatic ARSA treated by mediastinoscopy-assisted ligation at its origin and subclavian-carotid transposition.


Annals of Vascular Surgery | 2015

Open Surgical Treatment of a Severe Case of Obstructive Calcifying Aortic Disease

Pietro Rispoli; Gianfranco Varetto; Claudio Castagno; Paolo Garneri; Ugo Bertoldo; Simone Quaglino; Matteo Ripepi; Paolo Centofanti; Mauro Rinaldi

The obstructive calcifying aortic disease refers to severe calcifications of the descending aorta that obstruct or slow blood flow. Here, we report the case of a 65-year-old woman with recent onset of a very tight intermittent claudication and concomitant severe and uncontrolled hypertension, treated with a bypass graft between the proximal descending thoracic aorta and the supravisceral abdominal aorta.


BMC Urology | 2014

Inferior vena cava prosthetic replacement in a patient with horseshoe kidney and metastatic testicular tumor: technical considerations and review of the literature

Pietro Rispoli; P. Destefanis; Paolo Garneri; Gianfranco Varetto; B. Lillaz; Claudio Castagno; Patrizia Lista; Libero Ciuffreda; Dario Fontana

BackgroundSeminomatous and non-seminomatous Germ Cell Tumors (GCT) of the testis are a rare cancer, with an estimated incidence of 56.3 per million white males and 10 per million black males in the United States.The association between non-seminomatous GCT and horseshoe kidney is a rare event and is seen in about 1.3% of patients requiring retroperitoneal lymph node dissection. To our knowledge, no cases have been reported in which replacement of the IVC was also necessary.Case presentationWe report the case of a 22-year-old man with horseshoe kidney and metastatic non-seminomatous germ cell tumor involving the wall of the inferior vena cava.Following post-chemotherapy retroperitonal lymph node dissection, the inferior vena cava was replaced with an expanded polytetrafluoroethylene graft.At 2-years follow-up, the patient was in good health and the graft was patent. No clinical or diagnostic signs of renal impairment or recurrence of neoplastic disease were noted.ConclusionRadical surgery is warranted in patients with non-seminomatous germ cell tumor metastasizing to the retroperitoneal lymph nodes. When vena cava replacement is required, and the situation is further complicated by horseshoe kidney, as in this case, surgical technique will rely on multidisciplinary surgical treatment planning by a team composed of urologists, vascular surgeons and oncologists.

Collaboration


Dive into the Paolo Garneri's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge